Similar articles

• Texture Indices of 18F-FDG PET/CT for Differentiating Squamous Cell Carcinoma and Non-Hodgkin's Lymphoma of the Oropharynx.

  Mitamura K, Norikane T, Yamamoto Y, Ihara-Nishishita A, Kobata T, Fujimoto K, Takami Y, Kudomi N, Hoshikawa H, Nishiyama Y. Mitamura K, et al. Acta Med Okayama. 2021 Jun;75(3):351-356. doi: 10.18926/AMO/62230. Acta Med Okayama. 2021. PMID: 34176939
• Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC).

  Lodi Rizzini E, Repaci A, Tabacchi E, Zanoni L, Vicennati V, Cavicchi O, Pagotto U, Morganti AG, Fanti S, Monari F. Lodi Rizzini E, et al. Diagnostics (Basel). 2021 Aug 7;11(8):1430. doi: 10.3390/diagnostics11081430. Diagnostics (Basel). 2021. PMID: 34441364 Free PMC article.
• Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.

  Jans HS, Yang XH, Brocks DR, Kumar P, Wuest M, Wiebe LI. Jans HS, et al. J Pharm Pharm Sci. 2018;21(1s):32s-47s. doi: 10.18433/jpps29788. J Pharm Pharm Sci. 2018. PMID: 29702045
• Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging.

  Karantanis D, Allen-Auerbach M, Czernin J. Karantanis D, et al. Clin Nucl Med. 2012 May;37(5):e98-9. doi: 10.1097/RLU.0b013e318238f52d. Clin Nucl Med. 2012. PMID: 22475925
• Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.

  Berti A, Della-Torre E, Gallivanone F, Canevari C, Milani R, Lanzillotta M, Campochiaro C, Ramirez GA, Bozzalla Cassione E, Bozzolo E, Pedica F, Castiglioni I, Arcidiacono PG, Balzano G, Falconi M, Gianolli L, Dagna L. Berti A, et al. Rheumatology (Oxford). 2017 Dec 1;56(12):2084-2092. doi: 10.1093/rheumatology/kex234. Rheumatology (Oxford). 2017. PMID: 28977663